Jolanta Kunikowska on molecular targets for #theranostics in #glioma , #meningioma , and #brainmetastasis at #NMN2024
Matthias Preusser on the potential of #theranostics and radioligand therapies for #brainmetastases at #NMN2024
Very happy to chair session at #NMN2024 , where the state of the art in radiotheranostics for #neurooncology will be presented. Great organisation by Nathalie Albert and Matthias Preuser. Nuclear Medicine and Neurooncology (NMN)
Martin van den Bent on challenges and opportunities in clinical trial conduct for #theranostics in brain tumors at #NMN2024
Norbert Norbert Galldiks laying out the “clinicians wish list” on what should be visualized by PET. #NMN2024 Nuclear Medicine and Neurooncology (NMN) Forschungszentrum Jülich | @[email protected]
Great to meet Ulrike Harjes again under the neon lights of #NMN2024 . Nature Medicine Nuclear Medicine and Neurooncology (NMN) #Brain
PET RANO 1.0 criteria presented by Nathalie Albert at the #NMN2024 in Vienna.
thelancet.com/journals/lanon…
Nuclear Medicine and Neurooncology (NMN) EANO Editor - Neuro-Oncology Advances
Start of the very first meetings of the Nuclear Medicine and Neurooncology (NMN) with introductory words by Nathalie Albert and Matthias Preusser.
EANO SNO Editor - Neuro-Oncology Advances #PET #Theranostics #NMN2024 .
Active panel discussion at #NMN2024 on challenges and opportunities in clinical trial conduct.
Martin van den Bent Nuclear Medicine and Neurooncology (NMN) #NeuroOncology #theranostics SNMMI
Low Grade Glioma Registry @yalesph @bwhneutosurgery in attendance learning about what others are studying #lowgradeglioma #nmn2024 @nmnsymposium